DOCSLIB.ORG

Narcotic Drug Substances 1. 4-Methylnaphtaline-1-Il) (1-Pentyl-1 H-Indol-3-Il) Metanon-(JWH-122) and By-Products 2

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Narcotic Drug Substances 1. 4-Methylnaphtaline-1-Il) (1-Pentyl-1 H-Indol-3-Il) Metanon-(JWH-122) and By-Products 2 Narcotic Drug Substances 1. 4-Methylnaphtaline-1-il) (1-pentyl-1 H-indol-3-il) metanon-(JWH-122) and by-products 2. (4-Metoxynaphtaline-1 il) pentyl-1 H-indol-3il) metanone (JWH-122) and by-products 3. (Naphtaline-1-il) (4-penthyloxinaphtaline-1 il) metanone and by-products 4. (Naphtaline-1 il)(1-pentyl-1 H-indol-3-il) metanone - (JWH- 018) and by-products 5. 0-3 monoacethylmorphine 6. 0-6 monoacethylmorphine 7. 1-phenylpiperazine and by-products 8. 1-phenylcyclohexylamine and by-products 9. 2,5-Dimetoxyfenetylamine and by-products 10. 2C-B - (4 brom-2,5-dimetoxyfenetilamine) 11. 2C-T-7-(2,5-dimetoxy-4-N-propylthiofenetylamine) 12. 2-IY 1 R.3SY3- Hydroxycyclohexyl-5- (2-methylnonan-2-infenol - (CP 47.497)-C8) and by-products 13. 3 methylfentanyl 14. 3 methylthiofentanyl 15. 6-deeoxycoodeine 16. Alphameprodine 17. Alphametadole 18. Alpha-methylfentanyl 19. Alpha-methylthiofentanyl 20. Alphaprodine 21. Allylprodine 22. Amphetamine (Phenamine) 23. Anileridine 24. Acethyl alpha methylfentanyl 25. Acetorphine 26. Benzethidine 27. Beta hydroxy fentanyl 28. Beta hydroxy 3 methylfentanyl 29. Betameprodine 30. Betametadole 31. Betaprodine 32. Betasethilmetadole 33. Bezitramide 34. Desomorphine 35. Diampromide 36. Diphenoxine 37. Dimenoxadole 38. Dimepheptanol 39. Dimethylthiambutene 40. Dimetocaine - (3-diethylamino- 2,2-dimethylpropyl)- 4-aminobenzoate 41. Dioxahetyle butirate 42. Dipipanone 43. Diethylthiambutene 44. Ephedrine products 45. Efedrone 46. Ecgonine 47. Ethylmethylthiambutene 48. Etonitazene 49. Etorphine 50. Phenadoxone 51. Phenampromide 52. Phenatin 53. Fenfluramine 54. Phenomorphan 55. Phenoperidine 56. Hashish 57. Hashish oil 58. Heroin 59. Hydrocodone posphate 60. Hydroxypethidine 61. Poppy product (tranquilizer) 62. Poppy husk 63. Poppy husk, the extract 64. Isomethadone 65. Cathine 66. Cathinone 67. Ketobemidone 68. Clonitazene 69. Codoxime 70. Cocaine 71. Coca, the root 72. Levophenasilmorphan 73. Marihuana 74. Mephedrone-(4-methylmetkatinone) 75. Metilon- (3,4-methylendioxy-N-methylkatinone) 76. Metoxethamine-2-(3- metoxyfenyl)-2-(ethylamino) cyclohexanone and by-products 77. Mezembrine-3a-(3,4-dimetoxyfenyl-1- methylhexahydro-1 H-indole-6(2H)-on 78. MPPP (Methyl-alpha-Pyrrolidinopropiophenone) 79. Mitraginine (9-metoxy-corinanteidine) and by-products 80. Moramida, by-products 81. Morphine metobromide 82. Morphine-N-oxide 83. N-Butyl-1H-indole-3-i O (naphtaline-1-iD metanon-(JWH-073) and by-products 84. N-Dimethylamphetamine 85. Norasimetadol 86. Norcodeine 87. Normethadone 88. Normorphine 89. Norpipanone 90. Oripavine 91. Para-flourofentanyl 92. Parahexyl 93. Pethidine 94. Pethidine A,B,C byproduct 95. Piminodine 96. Prohethazine 97. Properidine 98. Pseudo ephedrine products 99. Salvinorin A 100. Thebaine 101. Thiofentanyl 102. Opium (also different extracts and acethylised forms, etc.) .
Load more

Recommended publications
  • Guidelines for Ensuring Patient Access To, and Safe Management Of, Controlled Medicines Notice
    African Palliative Care Association Guidelines for Ensuring Patient Access to, and Safe Management of, Controlled Medicines Notice Medicine is an ever-changing science. As new research and clinical experience broaden our knowledge, changes in treatment and drug therapy are required. APCA and the publisher of this work have checked with sources believed to be reliable in their efforts to provide information that is complete and generally in accord with the standards accepted at the time of this publication. However, in view of the possibility of human error or changes in sciences, neither APCA nor the publisher nor any other party who have been involved in the preparation or publication of this work warrants that the information contained in this publication is complete and correct and they disclaim all responsibility for any errors or omission or for the results obtained from use of the information contained herein. African Palliative Care Association Foreword The 59th Session of the World Health conventions. Several countries make the Assembly of the UN adopted resolution importation, storage, distribution and 58.22, thereby recognising the dispensing of controlled medicines more importance of improving pain relief restrictive than is needed. Additionally, using opioid analgesics and calling on it is a requirement for countries to member states to remove barriers to provide detailed annual estimates and their medical use and availability. reports for narcotic substances to the International Narcotic Control Board to While advances have been made pursuing procure or produce controlled medicines. this agenda in Africa (e.g. legalisation of However, formulating reliable estimates oral morphine prescription rights for nurses is often a barrier to accessing controlled and clinical officers in Uganda, approval medicines, while the procurement of access to morphine for hospices of opioids is subject to complex and in Zambia, and advocacy progress in lengthy exportation and importation Malawi and Kenya), challenges remain.
    [Show full text]
  • Narcotic Drugs and Psychotropic Substances (Control) Act
    LAWS OF GUYANA Narcotic Drugs and Psychotropic Cap. 35:11 3 Substances (Control) CHAPTER 35:11 NARCOTIC DRUGS AND PSYCHOTROPIC SUBSTANCES (CONTROL) ACT ARRANGEMENT OF SECTIONS PART I PRELIMINARY SECTION 1. Short title. 2. Interpretation. PART II PROHIBITION OF POSSESSION OF AND TRAFFICKING IN NARCOTICS AND CULTIVATION OF CERTAIN PLANTS 3. Definitions for Part II. 4. Penalty for possession of narcotic. 5. Penalty for trafficking in narcotic. 6. Penalty for supply, etc., of narcotic to child or young person if death results from consumption or administration of it. 7. Penalty for bringing into prison or taking out of prison, etc., of a narcotic. 8. Penalty for cultivation of certain plants. 9. Procedure for purposes of section 8(2) to (6). 10. Power of entry in respect of State or Government lands. 11. Power of destruction of prohibited plants. 12. Penalty for certain other acts connected with narcotics. 13. Certain prescriptions to be unlawful. 14. Penalty for receiving additional narcotic or prescription without disclosure of earlier receipt. 15. Removal of name from register. L.R.O. 3/1998 LAWS OF GUYANA 4 Cap. 35:11 Narcotic Drugs and Psychotropic Substances (Control) PART III NARCOTICS IN TRANSIT SECTION 16. Definitions for Part III. 17. Prohibition against sending narcotics by post. 18. Narcotics in transit. 19. Control of Comptroller over narcotics brought into Guyana in transit. 20. Tampering with narcotics in transit. 21. Diversion in Guyana of narcotics in transit. 22. Variations in export authorisation, import authorisation or diversion certificate granted in country other than Guyana. PART IV LICENCES 23. Grant and renewal of licences.
    [Show full text]
  • NOTIFICATION SPECIFYING SMALL QUANTITY and COMMERCIAL QUANTITYI Ly of the Pozoersconferred (Xxiiiil
    NOTIFICATION SPECIFYING SMALL QUANTITY AND COMMERCIAL QUANTITYI ly of the pozoersconferred (xxiiiil . - lleyise by clansesfuiia) and of section2 of the Nnrcotic Drrtgsnnd pnlchotropic SrtbstancesAct, 19g5 (61 of 1985)and in supersessionof Ministry of Ftnnnce, (D Departmentof'Reuenue Noiification s.o.527 aotra i'6tt,1uli, tssi, exceptas respects things doneor omitted to be done .beforesuch supersession,the Cential Gooernmenihereby spectfiesthe qtnntitrl ,nlnt'ionedin coltnnnsS and 6 of the Tablebelow, in relationto.the narcoticdrug or psychotropicsubstnnce mentioned.ii tlr', ,1urrponding entnl in columns2 to 4 of thesaid Table,as the small quantitrl nnd commercialquantity respectiailyfor the purposesof the said clnuse:sof ttrit seciion. TABLE [Seesub-clause vii(a) and xxiii(a) of section 2 of the Act] Sl No. Name of Narcotic Drug and Other non-proprietary Chemical Name Small Commercial Psychotropic Substance name Quanti- Quantity (Intemational non-proprietary ity (in (in gm./kg.) name (INN) Acetorphine 3-0-acetyltetrahydro-7-alpha-(l-hydroxy-l- methylbutyt)-o, l4-endoetheno-onpavine $ 50 9.. 1\) Acetyl-alpha-methylfen N-[-(alpha-methylphenethyl)-4-piperidy]l acetanilide 0.1 g-. J. Acetyldihydrocodeine 100 4. Acetylmethadol 3-acetoxy-6-dimethylamino-4, 4 lheptane 50 gm. 5. Alfentanil -ethyl-4, N-[1-[2-( 5-dihydro-S-oxo-lH-tetrazol-t-yt) 01 gm. ethyll-4-(methoxymethyl)-4-piperidinyll -N- ylpropanamide Allyprodine 3-allyl Jmethyl-4-phenyl-4 Alpha-3-acetoxy-6-dimethylamino-4,Ld lheptane 100 gm Alpha-3-ethyl-l-methyl-4-phenyl-4-propionox 50 gm. 9.7' AlphamethadolArPnametnaool Alpha-6-dimethylamino-4, 4-diphenyl-3-heptanol 2 S0 gm. 10. Alphu-*"thylf"ntur,yl 11.
    [Show full text]
  • Supplement 1: Additional Tables and Figures
    BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) BMJ Global Health Supplement 1: Additional tables and figures Box S1: Substances included and excluded from the International Narcotic Control Board (INCB) data on narcotic consumption, in alphabetical order. Opioids included in the opioid consumption calculation: 1. (+)-cis-3-methylfental 35. Bezitramide 2. 3-Acetylmorphine 36. Butyrfentanyl 3. 3-Methylfentanyl 37. Carfentanil 4. 3-Methylthiofentanyl 38. Carfentanyl 5. 3-Monoacetylmorphine 39. Clonitazene 6. 4-Fluoroisobutyrfentanyl 40. Codeine 7. 6-Acetylmorphine 41. Codeine-6GLUC 8. 6-Monoacetylmorphine 42. Codeine-6-glucuronide 9. Acetorphine 43. Codeine-Methyl 10. Acetyl-alpha-methylfentanyl 44. Codeine-N-oxide 11. Acetyldihydrocodeine 45. Codoxime 12. Acetylfentanyl 46. Conc. of poppy straw (C) ACA 13. Acetylmethadol 47. Conc. of poppy straw (C) AMA 14. Acetylmorphine 48. Conc. of poppy straw (C) AOA 15. Acrylfentanyl 49. Conc. of poppy straw (C) ATA 16. AH-7921 50. Conc. of poppy straw (C) GW 17. Alfentanil 51. Conc. of poppy straw (M) ACA 18. Allylprodine 52. Conc. of poppy straw (M) AMA 19. Alphacetylmethadol 53. Conc. of poppy straw (M) AOA 20. Alphameprodine 54. Conc. of poppy straw (M) ATA 21. Alphamethadol 55. Conc. of poppy straw (M) GW 22. alpha-Methylfentanyl 56. Conc. of poppy straw (N) GW 23. alpha-Methylthiofentanyl 57. Conc. of poppy straw (O) 24. Alphaprodine 58. Conc. of poppy straw (O) ACA 25. Anileridine 59. Conc. of poppy straw (O) AMA 26. Benzethidine 60. Conc. of poppy straw (O) AOA 27.
    [Show full text]
  • Dangerous Drugs Act
    MINISTRY OF THELAWS ATTORNEY OF TRINIDAD GENERAL AND AND LEGAL TOBAGO AFFAIRS www.legalaffairs.gov.tt DANGEROUS DRUGS ACT CHAPTER 11:25 Act 38 of 1991 Amended by 27 of 1994 173/1995 44 of 2000 *55 of 2000 11 of 2014 *See Note on page 2 Current Authorised Pages Pages Authorised (inclusive) by L.R.O. 1–2 .. 3–10 .. 11–12 .. 13–16 .. 17–46 .. 47–94 .. UNOFFICIAL VERSION L.R.O. UPDATED TO 31ST DECEMBER 2016 MINISTRY OF THE ATTORNEY GENERALLAWS OF AND TRINIDAD LEGAL AFFAIRS AND TOBAGOwww.legalaffairs.gov.tt 2 Chap. 11:25 Dangerous Drugs Index of Subsidiary Legislation Page Dangerous Drugs (Appointment of Inspectors) Order (LN 143/2001) … 47 Note on section 60 of Act Section 60 of the Act provides as follows: “60. (1) The following written laws are repealed: (a) the Narcotic Control Ordinance; and (b) the Narcotic Drugs and Psychotropic Substances Control Act, 1985. (2) Notwithstanding the repeal of the Ordinance and the Act referred to in subsection (1) anything done or any action taken under the Ordinance or the Act, shall be deemed to have been done or taken under the corresponding provisions of this Act.”. N.B. Subsidiary Legislation saved in respect of the above repealed statutes: 1. Dangerous Drugs Ordinance (Ch. 12. No. 6) (1950 Revised Edition)— (Repealed by Ord. No. 27 of 1961)— (a) Raw Opium and Ganja Regulations (1950 Rev. Ed.) Vol. 8 at page 521; (b) Dangerous Drugs Regulations (1950 Rev. Ed.) Vol 8 at page 515; (c) Power of Inspection Order 1963 (LN 104/1963).
    [Show full text]
  • 0 Cover Part Two\374
    PART TWO DEUXIÈME PARTIE SEGUNDA PARTE ﺍﳉﺰﺀ ﺍﻟﺜﺎﱐ 第二部分 ЧАСТЬ ВТΟΡАЯ - (...), [...] - (-)-3-hidroxi-N- (-)-(2R)-N-méthyl-1- fenacilmorfinán → Levophenacyl-morphan phénylpropan-2-amine → Levometamfetamine (-)-3-hidroxi-N- (-)-(3S,6R)-6- metilmorfinán → Levorphanol (dimethylamino)-4,4- (-)-3-hydroksymorfinan → Norlevorphanol diphenyl-3-heptanol → Betamethadol (-)-3-hydroksy-N- (-)-(3S,6R)-6- fenacylmorfinan → Levophenacyl-morphan (dimethylamino)-4,4- (-)-3-hydroksy-N- diphenyl-3-heptanol metylmorfinan → Levorphanol acetate (ester) → Betacetylmethadol (-)-3-hydroxymorphinan → Norlevorphanol (-)-(5R)-4,5-epoxy-3- (-)-3-hydroxy-N- methoxy-9α-methyl methylmorphinan → Levorphanol → Thebacon morphin-6-en-6-yl acetate (-)-3-hydroxynormorphinan → Norlevorphanol (-)-(5R,6S)-3-benzyloxy-4,5- (-)-3-hydroxy-N- epoxy-9a-methylmorphin- phenacylmorphinan → Levophenacyl-morphan 7-en-6-yl myristate → Myrophine (-)-3-hydroxytropane-2- (-)-(5R,6S)-4,5-epoxy carboxylat → Ecgonine morphin-7-en-3,6-diol → Normorphine (-)-3-idrossi-N- (-)-(5R,6S,14S)-4,5-epoxy- metilmorfinano → Levorphanol 14-hydroxy-3-methoxy- (-)-3-methoxy-N- 9a-methylmorphinan-6- methylmorphinan → Levomethorphan one → Oxycodone (-)-3-metil-2,2-difenil-4- (-)-(R)-4,5-epoxy-3- morfolinbutirilpirrolidina → Levomoramide methoxy-9a-methyl (-)-3-metoksy-N- morphinan-6-one → Hydrocodone metylmorfinan → Levomethorphan (-)-(R)-6-(dimethylamino)- (-)-3-metossi-N-metil- 4,4-diphenyl-3-heptanone → l-methadone morfinano → Levomethorphan (-)-(R)-N,α-dimethyl (-)-3-metoxi-N- phenethylamine → Levometamfetamine
    [Show full text]
  • Laws and Regulations Promulgated to Give Effect to the Provisions of the International Treaties on Narcotic Drugs and Psychotropic Substances
    E/NL. 1976/3 12 December 1978 Mf UNITED NATIONS ENGLISH AND SPANISH ONLY Original: SPANISH LAWS AND REGULATIONS PROMULGATED TO GIVE EFFECT TO THE PROVISIONS OF THE INTERNATIONAL TREATIES ON NARCOTIC DRUGS AND PSYCHOTROPIC SUBSTANCES CHILE Communicated by the Government of Chile NOTE BY THE SECRETARY GENERAL - In accordance with the relevant Articles of the International Treaties on Narcotic Drugs and Psychotropic Substances, the Secretary-General has the honour to communicate the following legislative text. Ministry of Public Health Directorate General of Health Technical Department ADDS THE DRUGS SPECIFIED TO THOSE ENUMERATED IN ARTICLE 2 OP THE NARCOTIC DRUGS REGULATIONS, SUPREME DECREE No. 137, of I96O 1/ No. 10,676 Santiago, 26 December 1974* Considering: that the Narcotic Drugs Regulations, Supreme Decree No. 137? of 12 March I96O l/ mention, in article 2 the substances which are deemed to be narcotic drugs and in article 4 authorize the Director General of Health to add to those enumerated in the said article 2, by a resolution to be published in the "Diario Oficial", any new drug or preparation of similar therapeutic action; that the list given in the said article 2 of the aforementioned Regulations and in the supplementary orders of later date does not include all the drugs which are now classified as narcotic drugs; that the latter should be considered to include those substances placed under international control by virtue of the corresponding Conventions and, in particular, the Single Convention on Narcotic Drugs, 1961, approved by the National Congress of Chile and adopted for enforcement as a law of the Republic by Supreme Decree No.
    [Show full text]
  • New Drug Substances with Abuse Potential
    New drug substances with abuse potential: Points to consider for the development and marketing - Regulatory environment in the European Union and the United States - Wissenschaftliche Prüfungsarbeit zur Erlangung des Titels „Master of Drug Regulatory Affairs“ der Mathematisch-Naturwissenschaftlichen Falkultät der Rheinischen Friedrich-Wilhems-Universität Bonn vorgelegt von Dr. Silke Jung Bonn 2006 Betreuer und 1. Referent: Dr. Winfried Kleinert, Bundesopiumstelle (BfArM) Zweiter Referent: RA Burkhard Stäter, Anwaltskanzlei Sträter To my husband - for his patience and support - Danksagung An erster Stelle möchte ich mich ganz herzlich bei Herrn Dr. Winfried Kleinert und Herrn RA Burkhard Sträter für die Betreuung und Unterstützung meiner Arbeit bedanken. Mein besonderer Dank gilt auch Herrn Dr. Joachim Heinze und Herrn Dr. Burkahrd Daldrup, die mir den Besuch des ergänzenden Studiengangs „Master of Drug Regulatory Affairs“ ermöglicht haben. Für die kritische Durchsicht meiner Arbeit und die vielen hilfreichen Anmerkungen danke ich meine Kolleginnen Dr. Gesine Bejeuhr, Dr. Kim Goldenstein, Dr. Maren Großmüller, Dr. Carol Huntington und Dr. Barbara Römer. Besonderer Dank gilt nicht zuletzt auch meiner Familie, vor allem meinem Mann Dr. Guido Thömmes, die meine Arbeit mit Liebe und Unterstützung begleitet hat. TABLE OF CONTENTS A1 Table of contents Table of contents......................................................................................................................... A1 Abbreviations.............................................................................................................................
    [Show full text]
  • The International Drug Control Conventions
    ST/CND/1/Add.1 The International Drug Control Conventions Schedules of the Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol, as at 25 September 2013 UNITED NATIONS New York, 2013 ST/CND/1/Add.1 © United Nations, 2013. All rights reserved, worldwide. Schedules of the Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol, as at 25 September 2013 List of drugs included in Schedule I Acetorphine 3-O-Acetyltetrahydro-7α-(1-hydroxy-1-methylbutyl)- 6,14-endo-ethenooripavine Acetyl-alpha-methylfentanyl N-[1-(α-Methylphenethyl)-4-piperidyl]acetanilide Acetylmethadol 3-Acetoxy-6-dimethylamino-4,4-diphenylheptane Alfentanil N-[1-[2-(4-Ethyl-4,5-dihydro-5-oxo-1H-tetrazol-1-yl) ethyl]-4-(methoxymethyl)-4-piperidinyl]-N- phenylpropanamide Allylprodine 3-Allyl-1-methyl-4-phenyl-4-propionoxypiperidine Alphacetylmethadol α-3-Acetoxy-6-dimethylamino-4,4-diphenylheptane Alphameprodine α-3-Ethyl-1-methyl-4-phenyl-4-propionoxypiperidine Alphamethadol α-6-Dimethylamino-4,4-diphenyl-3-heptanol alpha-methylfentanyl N-[1-(α-Methylphenethyl)-4-piperidyl]propionanilide alpha-methylthiofentanyl N-[1-[1-Methyl-2-(2-thienyl)ethyl]-4-piperidyl] propionanilide Alphaprodine α-l,3-Dimethyl-4-phenyl-4-propionoxypiperidine Anileridine 1-p-Aminophenethyl-4-phenylpiperidine-4-carboxylic acid ethyl ester Benzethidine 1-(2-Benzyloxyethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester Benzylmorphine 3-Benzylmorphine Betacetylmethadol β-3-Acetoxy-6-dimethylamino-4,4-diphenylheptane beta-Hydroxyfentanyl N-[1-(β-Hydroxyphenethyl)-4-piperidyl]
    [Show full text]
  • List of Narcotic Drugs Under International Control
    YELLOW LIST Annex to Forms A, B and C 46th edition, December 2004 LIST OF NARCOTIC DRUGS UNDER INTERNATIONAL CONTROL Prepared by the INTERNATIONAL NARCOTICS CONTROL BOARD* Vienna International Centre P.O. Box 500 A-1400 Vienna, Austria Internet address: http://www.incb.org/ in accordance with the Single Convention on Narcotic Drugs, 1961** Protocol of 25 March 1972 amending the Single Convention on Narcotic Drugs, 1961 ___________ * On 2 March 1968, this organ took over the functions of the Permanent Central Narcotics Board and the Drug supervisory Body, retaining the same secretariat and offices. ** Subsequently referred to as “1961 Convention”. 2007 Edition - List of prohibited articles 1 PURPOSE This document contains the current list of narcotic drugs under international control and additional information to assist governments in filling in the International Narcotics Control Board questionnaires related to narcotic drugs, namely, form A, form B and form C. It is divided into four parts: Part 1 gives a list of narcotic drugs under international control; it is subdivided into three sections: the first section listing those drugs included in Schedule I of the 1961 Convention and/or Group I of the 1931 Convention, the second section listing those drugs in Schedule II of the 1961 Convention and/or Group II of the 1931 Convention and the third section listing those drugs in Schedule IV of the 1961 Convention and/or Group II of the 1931 Convention. The names and descriptions used are those given in the 1961 Convention or in the official notifications of the Secretary-General of the United Nations.
    [Show full text]
  • Controlled Substances Act, 1984
    CONTROLLED SUBSTANCES ACT 1984 (SA) As at October 2014 Gaol terms are maximum and are in addition to any fine, court costs and levies Section Maximum Penalties Fine Gaol General offences s 13-15 Manufacture, produce, package, sale, supply etc, unless MD or licensed $10 000 - s 16/17 Unlawful sale of a poison $10 000 - s 17A(1) Manufacture, sell or supply a poison without permit from Minister $15 000 3 yrs (2) Possession of s17A precursor without a permit from the Minister $10 000 2 yrs (3) Sell a s17A precursor without producing a permit entitling person to possession $10 000 2 yrs s 17B(1) Sell a s17B precursor (exceptions) $10 000 3 yrs (2) Seller fails to keep records in relation to each sale $10 000 3 yrs (3) Seller fails to inform Commission of Police of suspicion that an order/enquiry for order of precursor may be connected to unlawful use $ 1 000 1 yr (4) Seller fails to keep precursors in secure storage, fails to retain written authorisation allowing others to have access, fails check stock after each sale $ 1 000 1 yr s 17C(1) Sell a s17C precursor to another person without duly completed end user statement $10 000 3 yrs (2) Seller fails to inform Commission of Police of suspicion that an order/enquiry for order of precursor may be connected to unlawful use $ 1 000 1 yr s 18 (1) Unlawful sale, supply or administer a prescription drug $10 000 2 yrs (2) Non qualified professional prescribe a prescription drug $10 000 2 yrs (3) Possess prescription drug without authority $10 000 2 yrs s 18A(a1) Unauthorised person prescribes drug
    [Show full text]
  • WO 2017/189947 Al 02 November 2017 (02.11.2017) W !P O PCT
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2017/189947 Al 02 November 2017 (02.11.2017) W !P O PCT (51) International Patent Classification: (US). REDDY, Madhava; 7 Oser Avenue, Hauppauge, A61K 31/485 (2006.01) A61K 47/12 (2006.01) New York 11720 (US). A61K 9/16 (2006.01) A61K 47/44 (2017.01) (74) Agent: SILVER, Robert S.; CAESAR RIVISE, P.C., A61K 9/48 (2006.01) Seven Penn Center, 12th Floor, 1635 Market Street, (21) International Application Number: Philadelphia, Pennsylvania 19103 (US). PCT/US20 17/030026 (81) Designated States (unless otherwise indicated, for every (22) International Filing Date: kind of national protection available): AE, AG, AL, AM, 28 April 2017 (28.04.2017) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, (25) Filing Language: English DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, (26) Publication Language: English HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, (30) Priority Data: MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, 15/140,844 28 April 2016 (28.04.2016) US PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, (71) Applicant: ASCENT PHARMACEUTICALS, INC. SD, SE, SG, SK, SL, SM, ST, SV, SY,TH, TJ, TM, TN, TR, [US/US]; 7 Oser Avenue, Hauppauge, New York 11720 TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
    [Show full text]